1. Despite waning effectiveness against SARS-CoV-2 infection, fully vaccinated patients continued to show low COVID-19 hospitalization rates up to 5 ...
1. Individuals not immune to COVID-19 had at least a 45% decreased risk of COVID-19 infection if at least one ...
1. A case series of 22 patients found that women and patients with an allergy history were more likely to ...
1. An interval of 44-45 weeks between the first and second dose resulted in a four-fold increase in median antibody ...
1. Heterologous AstraZeneca followed by Pfizer vaccination was noninferior to homologous, two-dose AstraZeneca vaccination with a geometric mean ratio of ...
1. In a large national survey, more than half of U.S. parents reported hesitancy in vaccinating their children against COVID-19. ...
1. An interim analysis of post-vaccination surveillance data for individuals who had received either Pfizer or Moderna mRNA COVID-19 vaccinations ...
1. The findings of this prospective cohort study suggested poor humoral immune response following a single dose of the BNT162b2 ...
Levels of antibodies against the trimeric spike protein and receptor-binding domain were 36- and 77-fold higher in the BNT162b2 group ...
1. Incidence of PCR-confirmed symptomatic COVID-19 cases was lower in the vaccine group compared with the placebo group (p<0.0001). 2. ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
